Cardio-Oncology
There is no content available at this time. Please check again later.
Relevant Content
Guideline-Directed Treatment of Venous Thromboembolism (VTE) Including Special Populations
Evaluating the Patient with VTE
Methodologic Standards for Follow-Up Extension in Cardiovascular Trials
What is VTE: Why Does it Matter?
HIF1α Attenuates Doxorubicin‐Induced Cardiotoxicity by Activating TEX264‐Associated ER‐phagy
Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities
Extension follow-up studies address long-term questions beyond the parent...
Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy
Polypharmacy is common in cardiovascular (CV) care because guideline-direc...
Transforming VTE Care: From Risk Identification to Protocol Implementation
Journal of the American Heart Association, Ahead of Print.
Background...
Researchers at Heart
Background...
Women's Health ... Guideline Publication Schedule ... ASCVD Risk Calculator HCM-AF Risk Calculator Combined Adult/Pediatric Hypertrophic Cardiomyopathy Calculator for Risk of Sudden ...
Cardio‐Oncologic Considerations in Heart Failure With Mildly Reduced Ejection Fraction: Prevalence and Prognostic Impact of Malignancies
Journal of the American Heart Association, Volume 15, Issue 12, June 16, 2...
